Leaderboards/Trigeminal Neuralgia and Treatments

Trigeminal Neuralgia and Treatments

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Anne Sofie Schott Andersen
Glostrup Hospital
2
Mohammad Al‐Mahdi Al‐Karagholi
Copenhagen University Hospital
3
Marcello Silvestro
University of Naples Federico II
4
Chia‐Chun Chiang
Stanford University
5
Johannes Herta
Medical University of Vienna
6
Mun Seng Chong
National Hospital for Neurology and Neurosurgery
7
Katie Traylor
University of Pittsburgh Medical Center
8
Umer Najib
West Virginia University
9
Jun Zhao
Beth Israel Deaconess Medical Center
10
Oralee J. Varnado
Eli Lilly (United States)

Rising Stars Papers

1
Potential treatment targets for migraine: emerging options and future prospects
The Lancet Neurology|2024
74 cit.
2
A large language model–based generative natural language processing framework fine‐tuned on clinical notes accurately extracts headache frequency from electronic health records
Headache The Journal of Head and Face Pain|2024
42 cit.
3
Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
Headache The Journal of Head and Face Pain|2024
30 cit.
4
PACAP38-induced migraine attacks are independent of CGRP signaling: a randomized controlled trial
The Journal of Headache and Pain|2025
20 cit.
5
Thermal management optimization strategy for lithium-ion battery based on phase change material and fractal fin
Journal of Energy Storage|2024
13 cit.
6
Migrainous infarction
Handbook of clinical neurology|2024
9 cit.
7
Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study
Patient Preference and Adherence|2024
6 cit.
8
Reduced neurovascular coupling of the visual network in migraine patients with aura as revealed with arterial spin labeling MRI: is there a demand-supply mismatch behind the scenes?
The Journal of Headache and Pain|2024
6 cit.
9
Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months: a US retrospective claims study
Current Medical Research and Opinion|2024
5 cit.
10
Thermal performance analysis of lightweight phase change envelopes
Energy and Buildings|2024
5 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jyun Yan Yang
Eli Lilly (United States)
2
魏延萍
Unknown
3
Michael Petrides
Montreal Neurological Institute and Hospital
4
A. Valle González
Christus Santa Rosa Health System
5
Stine Maarbjerg
Copenhagen University Hospital
6
Ming Zhang
Anhui Medical University
7
Philip R. Holland
King's College London
8
Fadia B. Dib-Hajj
Yale University
9
Christopher S. Walker
University of Auckland
10
Levi P. Sowers
University of Iowa

Emerging Leaders Papers

1
Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients
The Journal of Headache and Pain|2022
67 cit.
2
CGRP and the Calcitonin Receptor are Co-Expressed in Mouse, Rat and Human Trigeminal Ganglia Neurons
Frontiers in Physiology|2022
28 cit.
3
Efficacy of surgical treatment in patients with trigeminal neuralgia secondary to multiple sclerosis: A prospective study of 18 cases with evaluation of outcome and complications by independent evaluators
Cephalalgia|2023
22 cit.
4
CGRP Administration Into the Cerebellum Evokes Light Aversion, Tactile Hypersensitivity, and Nociceptive Squint in Mice
Frontiers in Pain Research|2022
21 cit.
5
Orexins and primary headaches: an overview of the neurobiology and clinical impact
Expert Review of Neurotherapeutics|2024
20 cit.
6
Intravenous fosphenytoin as treatment for acute exacerbation of trigeminal neuralgia: A prospective systematic study of 15 patients
Cephalalgia|2022
19 cit.
7
PAC1, VPAC1, and VPAC2 Receptor Expression in Rat and Human Trigeminal Ganglia: Characterization of PACAP-Responsive Receptor Antibodies
International Journal of Molecular Sciences|2022
11 cit.
8
Pharmacology of PACAP and VIP receptors in the spinal cord highlights the importance of the PAC<sub>1</sub> receptor
British Journal of Pharmacology|2024
11 cit.
9
Stimulation of CGRP-expressing neurons in the medial cerebellar nucleus induces light and touch sensitivity in mice
Neurobiology of Pain|2022
9 cit.
10
Trigeminal neuralgia and its comorbidities: a nationwide disease trajectory study
Pain|2024
8 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Peter J. Goadsby
King's College London
2
Jes Olesen
Glostrup Hospital
3
Rami Burstein
Beth Israel Deaconess Medical Center
4
Lars Edvinsson
Lund University
5
Arne May
Universität Hamburg
6
L. Dade Lunsford
University of Pittsburgh
7
Messoud Ashina
University of Copenhagen
8
Kim J. Burchiel
Oregon Health & Science University
9
Michel D. Ferrari
Leiden University
10
Gennaro Bussone
Fondazione IRCCS Istituto Neurologico Carlo Besta

Current Senior Leaders Papers

1
The International Classification of Headache Disorders: 2nd edition
The Lancet Neurology|2003
5.1k cit.
2
A Report on the Journal 2004
Cephalalgia|2004
2.4k cit.
3
Changes in grey matter induced by training
Nature|2004
2.4k cit.
4
The International Classification of Headache Disorders
Headache The Journal of Head and Face Pain|2008
2.3k cit.
5
Preface to the Second Edition
Cephalalgia|2004
2.1k cit.
6
Cost of disorders of the brain in Europe 2010
European Neuropsychopharmacology|2011
1.7k cit.
7
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache
Annals of Neurology|1990
1.6k cit.
8
The economic cost of brain disorders in Europe
European Journal of Neurology|2011
1.5k cit.
9
Epidemiology of headache in a general population—A prevalence study
Journal of Clinical Epidemiology|1991
1.5k cit.
10
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
New England Journal of Medicine|2004
1.2k cit.

Reagents for Trigeminal Neuralgia and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 64

MAPKAPK-2 (D1E11) Rabbit Monoclonal Antibody

#12155$194,416
View Evidence →
Cell Signaling TechnologyEvidence 66

Iba1/AIF-1 (E4O4W) Rabbit Monoclonal Antibody

#17198$1,821,015
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 68

DKK1 Antibody

#4687$317
View Evidence →
Cell Signaling TechnologyEvidence 67

CD10/Neprilysin (E5P7S) Rabbit Monoclonal Antibody (BSA and Azide Free)

#54370$865
View Evidence →
Cell Signaling TechnologyEvidence 63

p42 MAP Kinase (Erk2) Antibody

#9108$318
View Evidence →